Research progress of hydrogen sulfide in Alzheimer's disease from laboratory to hospital: a narrative review

Med Gas Res. 2020 Jul-Sep;10(3):125-129. doi: 10.4103/2045-9912.296043.

Abstract

Alzheimer's disease is a neurodegenerative disease that mainly occurs in old age and early stages. Its main manifestations are memory impairment, aphasia, apraxia, loss of identity, abstract thinking and impairment of computing power, personality and behavior changes, etc. At present, the treatment of Alzheimer's disease only stays on reducing the disease and delaying the development, which is also a difficult problem to overcome in clinical practice. Hydrogen sulfide, as a third gaseous signal molecule after carbon monoxide and nitrogen monoxide, has become very popular in recent years. It shows very promising prospects in the Alzheimer's disease model. It can protect the nerve function and prevent the progress of the disease by affecting the amyloid precursor protein metabolism, anti-apoptosis, anti-inflammatory, and antioxidant pathways. Therefore, this article summarizes the relevant basic and clinical research of hydrogen sulfide in Alzheimer's disease, and discusses its progress and findings and mechanism characteristics.

Keywords: Alzheimer’s disease; amyloid precursor protein metabolism; anti-apoptosis; anti-inflammation; antioxidation; hydrogen sulfide; synthesis and metabolism; therapy.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / prevention & control*
  • Amyloid beta-Peptides / metabolism
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology
  • Hospitals
  • Humans
  • Hydrogen Sulfide / chemistry*
  • Hydrogen Sulfide / metabolism
  • Hydrogen Sulfide / pharmacology
  • Laboratories
  • Neuroprotective Agents / chemistry*
  • Neuroprotective Agents / metabolism
  • Neuroprotective Agents / pharmacology
  • Signal Transduction

Substances

  • Amyloid beta-Peptides
  • Anti-Inflammatory Agents
  • Antioxidants
  • Neuroprotective Agents
  • Hydrogen Sulfide